Chinook Announces New Directors and Officers

Home / Press Release  / Chinook Announces New Directors and Officers

ERFURT, GERMANY, January 2nd, 2019 | Chinook Tyee Industry Limited (the “Company”) (TSXV:
XCX) announces that Dr. Stefan Feuerstein and Messrs. Alex Blodgett, Claudio Morandi and Ken MacLeod
were elected to the board of directors at the Company’s shareholder meeting.
Dr. Stefan Feuerstein who is also Managing Director of AMP Alternative Medical Products GmbH, a
wholly owned subsidiary of the Company, was appointed President while Mr. Blodgett was appointed Chief
Executive Officer of the Company.
About AMP Alternative Medical Products
AMP Alternative Medical Products GmbH, is a German biopharmaceutical company that provides cannabis
as a medicine to German patients by importing EU-GMP medical cannabis into Germany from Canada.
Canadian licence producers (LP) that enter into supply contracts with AMP are audited to ensure they meet
the stringent EU-GMP standards before AMP arranges EU-GMP certification in Germany to allow
importation. AMP is based in Erfurt in the state of Thuringia in central Germany and with offices in Berlin
and Vancouver, Canada. For further information, visit www.amp-eu.com, Twitter or Instagram.
About Chinook
Chinook Tyee Industry Limited is a European investment holding company that trades on the TSX Venture
Exchange under the symbol, “XCX”. Chinook has 10,217,796 fully diluted shares issued and outstanding,
and its primary investment is AMP Alternative Medical Products GmbH.
Neither the TSXV nor its Regulation Service Provider (as that term is defined in the policies of the TSXV)
accepts responsibility for the adequacy or accuracy of this release.